# Day – 3 Glimpses, 26th February, 2022
# Session 1 on Deficiencies in BA/BE studies by Dr. Haresh Patel, Senior Manager at Sun Pharmaceutical Industries, Vadodara, Gujarat, India.
# Session 2 on Stability testing requirements by Ms. Dipa Mehta, Manager of Pharmazone, Ahmedabad
# Session 3 on Regulatory Exclusivity and Patent Exclusivities for US and Europe by Mr. Sanjaykumar Patel, Patent Attorney & Star-up mentor, Excelon IP Patent & Trademark Attorney.
# Session 4 on Drug Submission Procedure Quality Expectation: Health Canada by Mr. Pranav Pandya, Deputy General Manger, Regulatory Affairs at Sun Pharmaceutical Industries Ltd., Vadodara.
